Compare COR & CRDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | COR | CRDO |
|---|---|---|
| Founded | 2001 | 2008 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Other Pharmaceuticals | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.9B | 50.7B |
| IPO Year | 2001 | 2022 |
| Metric | COR | CRDO |
|---|---|---|
| Price | $331.41 | $170.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 14 |
| Target Price | ★ $390.62 | $179.62 |
| AVG Volume (30 Days) | 1.2M | ★ 5.5M |
| Earning Date | 05-06-2026 | 06-01-2026 |
| Dividend Yield | ★ 0.77% | N/A |
| EPS Growth | 5.71 | ★ 765.52 |
| EPS | ★ 15.21 | 0.67 |
| Revenue | ★ $321,332,819,000.00 | $1,335,116,000.00 |
| Revenue This Year | $8.89 | $210.92 |
| Revenue Next Year | $6.75 | $57.22 |
| P/E Ratio | ★ $22.12 | $246.94 |
| Revenue Growth | 9.31 | ★ 205.68 |
| 52 Week Low | $244.82 | $86.49 |
| 52 Week High | $377.54 | $308.67 |
| Indicator | COR | CRDO |
|---|---|---|
| Relative Strength Index (RSI) | 65.64 | 31.79 |
| Support Level | $331.73 | $156.87 |
| Resistance Level | $350.77 | $207.91 |
| Average True Range (ATR) | 6.19 | 14.60 |
| MACD | 1.01 | -8.41 |
| Stochastic Oscillator | 91.90 | 2.82 |
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
Credo Technology Group Holding Ltd provides connectivity solutions for AI-driven applications, cloud computing, and hyperscale networks. Its high-speed copper and optical interconnect products support data infrastructure demands. The Company's product portfolio includes ZeroFlap (ZF) Active Electrical Cables (AECs), ZF optical transceivers, OmniConnect memory solutions, and retimers and DSPs for optical and copper Ethernet and PCIe, leveraging the PILOT diagnostic and analytics software platform. Its products are based on Serializer/Deserializer (SerDes) and Digital Signal Processor (DSP) technologies and include integrated circuits (ICs), Active Electrical Cables (AECs), SerDes Chiplets, and SerDes IP licensing solutions. The United States generates the maximum revenue.